0001144204-12-020647.txt : 20120409 0001144204-12-020647.hdr.sgml : 20120409 20120409090120 ACCESSION NUMBER: 0001144204-12-020647 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120405 FILED AS OF DATE: 20120409 DATE AS OF CHANGE: 20120409 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KERYX BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0001114220 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 134087132 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 750 LEXINGTON AVENUE STREET 2: . CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-531-5965 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Tarnok Michael P. CENTRAL INDEX KEY: 0001413525 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30929 FILM NUMBER: 12748889 BUSINESS ADDRESS: BUSINESS PHONE: (212) 531-5965 MAIL ADDRESS: STREET 1: KERYX BIOPHARMACEUTICALS, INC. STREET 2: 750 LEXINGTON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 4 1 v308708_4.xml OWNERSHIP DOCUMENT X0305 4 2012-04-05 0 0001114220 KERYX BIOPHARMACEUTICALS INC KERX 0001413525 Tarnok Michael P. KERYX BIOPHARMACEUTICALS, INC. 750 LEXINGTON AVENUE NEW YORK NY 10022 1 0 0 0 Common Stock 2012-04-05 4 P 0 17500 1.55 A 278600 D Of the 278,600 shares, 25,000 are shares of restricted stock. /s/ James F. Oliviero, III, Attorney-in-Fact 2012-04-05